The ACA promotion has published a list highlighting fighters with the cleanest records in drug testing. The announcement was made via their official channels, though specific names were not included in the post. This initiative appears to be part of the organization's efforts to promote clean competition and transparency in drug testing protocols. No further details about the criteria used or the complete list of fighters were provided in the brief announcement. The post generated interest about whether the organization would release a corresponding list of fighters with positive or problematic test results.
ACA has moved to publicly recognize fighters within its promotion who carry the cleanest drug testing records, announcing the initiative through its official channels on April 26, 2026.
The Russian-based organization framed the release as part of a broader commitment to clean competition and transparency in its anti-doping protocols. No specific fighter names were included in the initial announcement, and the promotion did not outline the criteria used to determine which athletes qualified for recognition on the list.
Why it matters
- Publicly spotlighting fighters with clean testing records signals a deliberate effort by ACA to position itself as accountable on anti-doping issues.
- The absence of named fighters or clear criteria leaves the scope and credibility of the initiative open to interpretation.
- The announcement prompted discussion about whether ACA intends to follow up with disclosure of fighters who have received positive or otherwise problematic test results, which would represent a significantly more consequential level of transparency.
The announcement drew attention within MMA circles largely because of what it did not include. A list without names offers limited verifiable information, and the promotion has not yet indicated when or whether a full accounting of its testing data would be made available. Whether this initiative develops into a comprehensive anti-doping transparency effort will depend on the details ACA chooses to release in any follow-up communication.
